CAMP4 Therapeutics
CAMP
29 hedge funds and large institutions have $17M invested in CAMP4 Therapeutics in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 17 closing their positions.
4.63% less ownership
Funds ownership: 62.88% → 58.25% (-4.6%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
26% less funds holding
Funds holding: 39 → 29 (-10)
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
59% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 17
66% less capital invested
Capital invested by funds: $50.7M → $17M (-$33.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$265K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$189K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$49.8K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$29.6K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$29.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$2.54M |
| 2 |
BlackRock
New York
|
-$422K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$316K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$168K |
| 5 |
State Street
Boston,
Massachusetts
|
-$105K |
CAMP Hedge Fund Activity: Q2 2025 in Review
29 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in CAMP4 Therapeutics (CAMP) for Q2 2025, worth a combined $17M — down 66% from $50.7M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of CAMP and 7 opened new positions — a net loss of 10 holders — while 11 trimmed existing stakes and 6 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $265K. The largest seller was Franklin Resources, exiting entirely with an estimated $2.54M sold.
- 29 institutional investors held CAMP4 Therapeutics (CAMP) as of Q2 2025, down from 39 in Q1 2025.
- Funds reported $17M of CAMP4 Therapeutics stock for Q2 2025, down 66% quarter-over-quarter.
- 7 funds opened new CAMP4 Therapeutics positions in Q2 2025 and 17 closed out, a net change of -10 holders.
- The largest CAMP4 Therapeutics buyer in Q2 2025 was Millennium Management, an estimated $265K added.
- The largest CAMP4 Therapeutics seller in Q2 2025 was Franklin Resources, an estimated $2.54M sold.
Based on aggregated 13F filings for Q2 2025.